HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Anish Bhardwaj Selected Research

Halothane (Fluothane)

9/2008The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema.
1/2007Effect of osmotherapy with hypertonic saline on regional cerebral edema following experimental stroke: a study utilizing magnetic resonance imaging.
7/2006Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke.
5/2006Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy.
3/2006Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide.
7/2005Ischemic neuroprotection with selective kappa-opioid receptor agonist is gender specific.
1/2005Increases in lung and brain water following experimental stroke: effect of mannitol and hypertonic saline.
5/2004Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats.
12/2003Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats.
6/2003Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Anish Bhardwaj Research Topics

Disease

14Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2010 - 02/2003
12Brain Edema (Cerebral Edema)
08/2010 - 07/2002
10Ischemia
08/2010 - 02/2003
9Stroke (Strokes)
07/2011 - 01/2005
7Brain Injuries (Brain Injury)
04/2010 - 07/2003
6Brain Ischemia (Cerebral Ischemia)
05/2007 - 03/2003
4Seizures (Seizure)
07/2011 - 04/2004
4Edema
08/2010 - 07/2002
4Hyponatremia
01/2009 - 03/2004
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
02/2012 - 06/2005
3Nervous System Diseases (Neurological Disorders)
07/2011 - 02/2006
3Neoplasms (Cancer)
07/2011 - 07/2002
3Brain Neoplasms (Brain Tumor)
04/2010 - 07/2002
3Spinal Cord Injuries (Spinal Cord Injury)
04/2010 - 07/2003
2Pneumonia (Pneumonitis)
02/2012 - 12/2002
2Infection
07/2011 - 08/2010
2Hyperventilation
08/2010 - 01/2007
2Wounds and Injuries (Trauma)
08/2010 - 02/2007
2Myasthenia Gravis
02/2010 - 12/2002
2Infarction
08/2006 - 03/2002
2Heart Arrest (Cardiac Arrest)
10/2004 - 03/2003
1Ulcer
02/2012
1Graft vs Host Disease (Graft-Versus-Host Disease)
07/2011
1Central Pontine Myelinolysis
07/2011
1Pneumocephalus
08/2010
1Hydrocephalus (Hydrocephaly)
08/2010
1Intracranial Hemorrhages (Intracranial Hemorrhage)
04/2010
1Critical Illness (Critically Ill)
02/2010
1Demyelinating Diseases (Demyelinating Disease)
02/2010
1Encephalomyelitis (Myeloencephalitis)
02/2010
1Multiple Sclerosis
02/2010
1Hemorrhagic Shock
02/2007
1Dehydration (Water Stress)
01/2007
1Hypotension (Low Blood Pressure)
01/2007
1Bacterial Meningitis
06/2005
1Cerebral Hemorrhage
06/2005
1Inflammation
06/2005
1Ataxia (Dyssynergia)
06/2004
1Neurologic Manifestations (Neurological Manifestations)
06/2004
1Water Intoxication
03/2004
1Hypothermia
12/2003
1Transient Ischemic Attack
02/2003

Drug/Important Bio-Agent (IBA)

10Halothane (Fluothane)FDA Link
09/2008 - 06/2003
51- (3,4- dichlorophenyl)acetyl- 2- (1- pyrrolidinyl)methylpiperidineIBA
03/2006 - 06/2003
4Arginine Vasopressin (Argipressin)IBA
02/2010 - 02/2006
4Mannitol (Osmitrol)FDA LinkGeneric
07/2006 - 07/2002
4kappa Opioid Receptors (kappa Opioid Receptor)IBA
03/2006 - 06/2003
3Aquaporin 4IBA
08/2010 - 09/2008
3syntrophin alpha1IBA
08/2010 - 02/2003
3IsofluraneFDA LinkGeneric
08/2010 - 12/2008
3Adrenal Cortex Hormones (Corticosteroids)IBA
02/2010 - 07/2002
3DiureticsIBA
01/2007 - 03/2002
3Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2006 - 06/2003
3salicylhydroxamic acid (SHAM)IBA
05/2006 - 06/2004
2Anticonvulsants (Antiepileptic Drugs)IBA
02/2012 - 01/2007
2Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
02/2010 - 02/2006
2Hypertonic Saline SolutionIBA
02/2007 - 04/2004
2HormonesIBA
02/2006 - 07/2005
2MethylprednisoloneFDA LinkGeneric
06/2005 - 07/2003
2Dopamine (Intropin)FDA LinkGeneric
05/2004 - 02/2003
1Neuroprotective AgentsIBA
02/2012
1Sucralfate (Carafate)FDA LinkGeneric
02/2012
1OxygenIBA
08/2010
1Bumetanide (Bumex)FDA LinkGeneric
08/2010
1Nitrous Oxide (Laughing Gas)IBA
08/2010
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
04/2010
1Intravenous Immunoglobulins (IVIG)FDA Link
02/2010
1sigma Receptors (sigma Receptor)IBA
05/2007
11,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA
09/2006
1triphenyltetrazoliumIBA
08/2006
1Psychotropic Drugs (Psychoactive Drugs)IBA
02/2006
1SodiumIBA
02/2006
1Vasopressins (Vasopressin)IBA
02/2006
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2005
1Serotonin (5 Hydroxytryptamine)IBA
06/2005
1GlucocorticoidsIBA
06/2005
1Biological Markers (Surrogate Marker)IBA
10/2004
1Intervertebral disc diseaseIBA
04/2004
1Complement System Proteins (Complement)IBA
03/2004
1norbinaltorphimineIBA
12/2003

Therapy/Procedure

5Intravenous Infusions
09/2008 - 07/2002
4Critical Care
02/2010 - 12/2002
4Resuscitation
11/2007 - 04/2002
3Neurosurgical Procedures
08/2010 - 02/2006
3Suture Techniques
02/2010 - 02/2003
2Intensive Care (Surgical Intensive Care)
02/2012 - 02/2010
2Anesthesia
08/2010 - 06/2004
1Drug Therapy (Chemotherapy)
07/2011
1Transplantation (Transplant Recipients)
07/2011
1Transplants (Transplant)
07/2011
1Epidural Anesthesia
08/2010
1Spinal Anesthesia
08/2010
1Plasmapheresis
02/2010
1Immunomodulation
02/2010
1Deep Brain Stimulation
06/2005
1Thoracotomy
06/2004
1Intervertebral Disk Chemolysis (Discolysis)
04/2004
1Lasers (Laser)
12/2003
1Perioperative Period
03/2003
1Decompressive Craniectomy
01/2003